Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?

Guobin He, Debanjan Dhar, Hayato Nakagawa, Joan Font-Burgada, Hisanobu Ogata, Yuhong Jiang, Shabnam Shalapour, Ekihiro Seki, Shawn Yost, Kristen Jepsen, Kelly A. Frazer, Olivier Harismendy, Maria Hatziapostolou, Dimitrios Iliopoulos, Atsushi Suetsugu, Robert M. Hoffman, Ryosuke Tateishi, Kazuhiko Koike,

Authors

SG
Sergei I. Grivennikov
Michael Karin
University of California, San Diego

Discussion(0)

No comments yet. Be the first to comment.

Publication Info

DOI: 10.1016/j.ccr.2007.12.020
Year: 2008
Published: —
Language: en

Article Details

Volume: 13
Issue: 1
Link Of The Paper: https://doi.org/10.1016/j.ccr.2007.12.020

Timeline

Created:June 19, 2026

Michael Karin

Article1996

IL-6 is an in vitro and in vivo autocrine growth factor for middle T antigen-transformed endothelial cells

Enrico Giraudo, Marco Arese, Carlo Toniatti, Marina Strasly, Luca Primo, Alberto Mantovani, Gennaro Ciliberto, F Bussolini

Article2015

Autocrine signaling of type 1 interferons in successful anticancer chemotherapy.

Erika Vacchelli, Antonella Sistigu, Takahiro Yamazaki, Ilio Vitale, Laurence Zitvogel, Guido Guido Kroemer

Chapter in a book2001

IL-6

Katherine A. Fitzgerald, Luke O'neill, Andy J.H. Gearing, Robin E. Callard

Article2010

Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression

Eek Joong Park, Jun Hee Lee, Guann‐Yi Yu, Guobin He, Syed R. Ali, Ryan G. Holzer, Christoph H. Österreicher, Hiroyuki Takahashi, Michael Karin